Clinical Trial Update: Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With NF1 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical diclofenac after laser microporation for cutaneous neurofibromas in Neurofibromatosis type 1 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Drugs mentioned

• Diclofenac topical solution (topical liquid) (diclofenac)

Snippet

Sponsor: Fundação Educacional Serra dos Órgãos | Conditions: Neurofibromatosis 1, Cutaneous Neurofibroma | Phase 2 | Status: COMPLETED